S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 SoligenixInnovate BiopharmaceuticalsAdvaxisCumberland PharmaceuticalsAeterna Zentaris
SymbolNASDAQ:SNGXNASDAQ:INNTNASDAQ:ADXSNASDAQ:CPIXNASDAQ:AEZS
Price Information
Current Price$1.63$1.74$0.88$3.39$1.15
52 Week RangeBuyN/AN/ABuyN/A
MarketRank™
Overall Score1.40.50.60.70.6
Analysis Score3.30.00.00.00.0
Community Score2.92.42.42.22.9
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.80.0
Earnings & Valuation Score0.60.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyN/AN/ABuyN/A
Consensus Price Target$3.44N/AN/AN/AN/A
% Upside from Price Target110.89% upsideN/AN/AN/AN/A
Trade Information
Market Cap$51.32 million$71.91 million$98.78 million$50.91 million$85.09 million
Beta1.42-0.393.180.322.1
Average Volume5,175,483525,98217,626,12383,62225,028,686
Sales & Book Value
Annual Revenue$4.60 millionN/A$20.88 million$47.53 million$530,000.00
Price / Sales11.16N/A4.731.07160.55
CashflowN/AN/AN/A$0.54 per shareN/A
Price / CashN/AN/AN/A6.25N/A
Book Value$0.07 per share($0.27) per share$2.30 per share$3.36 per share($0.12) per share
Price / Book23.29N/A0.381.01-9.58
Profitability
Net Income$-9,360,000.00$-27,050,000.00$-16,610,000.00$-3,540,000.00$-6,040,000.00
EPS($0.48)N/AN/A$0.23N/A
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-567.04%N/A-13,144.62%-8.36%-369.10%
Return on Equity (ROE)-328.25%N/A-81.49%3.86%-125.54%
Return on Assets (ROA)-140.08%-234.42%-66.32%1.92%-21.45%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%N/AN/A0.31%N/A
Current Ratio2.30%0.35%8.40%2.04%12.98%
Quick Ratio2.30%0.35%8.40%1.62%12.77%
Ownership Information
Institutional Ownership Percentage9.39%5.88%10.50%26.15%2.44%
Insider Ownership Percentage3.09%7.90%0.26%39.72%N/A
Miscellaneous
Employees1581794N/A
Shares Outstanding31.49 million41.33 million111.97 million15.02 million73.99 million
Next Earnings Date3/29/2021 (Estimated)N/A3/12/2021 (Estimated)3/17/2021 (Estimated)3/29/2021 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.